The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback